➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: October 31, 2020

DrugPatentWatch Database Preview

Peginterferon alfa-2b - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for peginterferon alfa-2b

Tradenames:	2
Patents:	33
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for peginterferon alfa-2b

Recent Clinical Trials for peginterferon alfa-2b

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Shanghai Cancer Hospital, China	Phase 2
Icahn School of Medicine at Mount Sinai	Phase 2
University Health Network, Toronto	Phase 2

See all peginterferon alfa-2b clinical trials

Pharmacology for peginterferon alfa-2b

Ingredient-type	Interferon Alfa-2b Interferon-alpha

Company Disclosures: US Patents for peginterferon alfa-2b

These patents were extracted from company disclosures

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Enzon, Inc. (Piscataway, NJ)	2013-11-10	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Enzon, Inc. (Piscataway, NJ)	2013-11-10	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2015-11-02	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2018-03-26	RX		company
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Schering Corporation (Kenilworth, NJ)	2018-03-26	RX		company
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

Patent Text Search: US Patents for peginterferon alfa-2b

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Abbott Laboratories (Abbott Park, IL)	2023-03-24	RX		search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Intermune, Inc. (Brisbane, CA)	2025-03-08	RX		search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Roche Palo Alto LLC (Palo Alto, CA)	2039-02-26	RX		search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	Intermune, Inc. (Brisbane, CA)	2025-03-08	RX		search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	IBC Pharmaceuticals, Inc. (Morris Plains, NJ)	2025-04-06	RX		search
Schering	PEGINTRON	peginterferon alfa-2b	VIAL	103949	001	2001-01-19	Start Trial	IBC Pharmaceuticals, Inc. (Morris Plains, NJ)	2025-04-06	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for peginterferon alfa-2b

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	5600500	Start Trial
European Patent Office	3548088	Start Trial
Canada	2965665	Start Trial
Portugal	975369	Start Trial
Australia	552004	Start Trial
Germany	3125706	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

AstraZeneca

Mallinckrodt

Johnson and Johnson

Boehringer Ingelheim

Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.